RecruitingAtopic Dermatitis
Registry for Systemic Eczema Treatments
Eligible age
1–26 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.
Sponsor: Johns Hopkins University
You may qualify if…
- ✓ Age \<26 years old
- ✓ Current physician diagnosis of atopic dermatitis
- ✓ Provide signed informed consent if ≥ 18 years old
- ✓ Provide signed informed consent by parent or legal guardian (if \<18 years old) and informed assent if applicable
- ✓ Subject and/or parent/legal guardian is willing to be contacted in the future by study staff
- ✓ Seen for clinical care at Johns Hopkins since 1/1/2017
- ✓ Previously on, currently on, or planning to initiate (within next 6 months) a systemic AD therapy
You may not qualify if…
- ✕ Age ≥26 years old at the time of registry enrollment
- ✕ Does not speak English
- ✕ If \<18 years old, has a primary caretaker who does not speak English
- ✕ If \<18 years old, parent/legal guardian is unwilling to sign the written informed consent
- ✕ Is a foster child
- ✕ Has not received clinical care at Johns Hopkins since 1/1/2017
Where it's recruiting
Maryland
Baltimore
Source: ClinicalTrials.gov · NCT06136767 · last updated 2026-04-07